- Home
- SGMT vs LANV Comparison
SGMT vs LANV Comparison
Compare SGMT & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SGMT | LANV |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.2M | 204.7M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGMT | LANV |
|---|---|---|
| Price | $6.35 | $1.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $29.71 | N/A |
| AVG Volume (30 Days) | ★ 504.2K | 20.8K |
| Earning Date | 03-11-2026 | 08-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $341,783,911.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.90 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.73 | $1.42 |
| 52 Week High | $11.41 | $2.69 |
Technical Indicators
Market Signals| Indicator | SGMT | LANV |
|---|---|---|
| Relative Strength Index (RSI) | 53.90 | 35.69 |
| Support Level | $5.95 | $1.68 |
| Resistance Level | $6.42 | $1.82 |
| Average True Range (ATR) | 0.31 | 0.15 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 77.04 | 11.76 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.